What is Biote Corp.'s cash & equivalents?

Biote Corp. (BTMD) reported cash & equivalents of $5.32M in Q1 2026.

How has Biote Corp.'s cash & equivalents changed year-over-year?

Biote Corp.'s cash & equivalents decreased by 87.2% year-over-year, from $41.7M to $5.32M.

What is the long-term trend for Biote Corp.'s cash & equivalents?

Over 5 years (2020 to 2025), Biote Corp.'s cash & equivalents has grown at a 585.5% compound annual growth rate (CAGR), from $1.59K to $24.12M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Biote Corp. BTMD Cash & Equivalents

Cash & Equivalents at other companies

TargetTGT

$3.53B+22.4%

Walmart WMT

$11.32B+14.0%

Lifecore Biomedical, Inc.LFCR

$20.8M+152%

BioLife SolutionsBLFS

$22.82M-65.9%

NAG

Niagen Bioscience, Inc. Common StockNAGE

$66.55M+19.7%

Lifevantage CorporationLFVN

$12.48M-44.4%

Other financials

Income statement

See full

Revenue$44.9M-8.3%

Gross profit$31.0M-14.9%

Operating income$3.2M-67.3%

Net income$2.3M-83.4%

EPS (diluted)$0.06-83.8%

Balance sheet

See full

Total debt$103.4M-5.5%

Total equity-$56.1M+37.7%

Total assets$89.0M-27.8%

Cash flow

See full

Operating cash flow$3.9M-39.7%

CapEx$362.0K-77.8%

Free cash flow$3.5M-26.8%

Valuation

See full

Market cap$57.33M-57.5%

Enterprise value$155.43M-30.3%

P/E3.7×-0.6×

P/S0.3×-0.4×

Profitability

See full

Gross margin70.1%-1.2pp

Operating margin15.4%-0.1pp

Net margin8.3%-2.3pp

FCF margin15.3%-3.2pp

Returns & leverage

See full

Return on equity-21.4%—

Debt / equity9.1×—

Current ratio1.3×-0.1×

Where this comes from

Reported directly by Biote Corp. in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Biote Corp.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biote Corp.'s cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biote Corp.'s cash & equivalents?: Biote Corp. (BTMD) reported cash & equivalents of $5.32M in Q1 2026.
How has Biote Corp.'s cash & equivalents changed year-over-year?: Biote Corp.'s cash & equivalents decreased by 87.2% year-over-year, from $41.7M to $5.32M.
What is the long-term trend for Biote Corp.'s cash & equivalents?: Over 5 years (2020 to 2025), Biote Corp.'s cash & equivalents has grown at a 585.5% compound annual growth rate (CAGR), from $1.59K to $24.12M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.